Skip to main content
Erschienen in: International Journal of Clinical Oncology 3/2010

01.06.2010 | Original Article

Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer

verfasst von: Hisashi Imai, Ryuichiro Doi, Hiroyuki Kanazawa, Naoko Kamo, Masayuki Koizumi, Toshihiko Masui, Yasuhiro Iwanaga, Yoshiya Kawaguchi, Yasutsugu Takada, Hiroyoshi Isoda, Shinji Uemoto

Erschienen in: International Journal of Clinical Oncology | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Para-aortic lymph node (PALN) metastasis is an important prognostic factor in patients with pancreatic cancer, but accurate preoperative diagnosis is difficult. The objective of this study was to assess the accuracy of diagnosis of PALN by computed tomography (CT), magnetic resonance imaging (MRI), and 18F-fluorodeoxyglucose positron-emission tomography (FDG-PET).

Methods

From August 2005 to July 2008, 119 patients with invasive ductal adenocarcinoma of the pancreas were included in this study. PALNs with a longer diameter >10 mm on CT or MRI were suspected of being involved by metastasis, whereas FDG uptake exceeding that of the adjacent normal tissue was considered to be positive for metastasis on FDG-PET studies. The imaging findings were compared with the pathological diagnosis of PALN metastasis.

Results

PALN dissection was performed in 71 patients (60.0%). Although histopathological examination revealed metastasis in 6 patients (8.5%), none of these patients was positive in any of the preoperative imaging studies. The longer diameter, the shorter diameter, the ratio of the two diameters, and the calculated lymph node volume showed no significant differences between patients with and without PALN metastasis.

Conclusions

Preoperative detection of PALN metastasis in patients with pancreatic cancer is very difficult. Intraoperative histopathological examination of frozen sections is necessary if radical resection is contemplated.
Literatur
1.
Zurück zum Zitat Matsuno S, Egawa S, Fukuyama S et al (2004) Pancreatic Cancer Registry in Japan: 20 years of experience. Pancreas 28:219–230CrossRefPubMed Matsuno S, Egawa S, Fukuyama S et al (2004) Pancreatic Cancer Registry in Japan: 20 years of experience. Pancreas 28:219–230CrossRefPubMed
2.
Zurück zum Zitat Herrmann R, Jelic S (2008) Pancreatic cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19(Suppl 2):ii25–ii26CrossRefPubMed Herrmann R, Jelic S (2008) Pancreatic cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19(Suppl 2):ii25–ii26CrossRefPubMed
3.
Zurück zum Zitat Riall TS, Cameron JL, Lillemoe KD et al (2005) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma–part 3: update on 5-year survival. J Gastrointest Surg 9:1191–1204 (discussion 204–206)CrossRefPubMed Riall TS, Cameron JL, Lillemoe KD et al (2005) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma–part 3: update on 5-year survival. J Gastrointest Surg 9:1191–1204 (discussion 204–206)CrossRefPubMed
4.
Zurück zum Zitat Doi R, Kami K, Ito D et al (2007) Prognostic implication of para-aortic lymph node metastasis in resectable pancreatic cancer. World J Surg 31:147–154CrossRefPubMed Doi R, Kami K, Ito D et al (2007) Prognostic implication of para-aortic lymph node metastasis in resectable pancreatic cancer. World J Surg 31:147–154CrossRefPubMed
5.
Zurück zum Zitat Kayahara M, Nagakawa T, Ohta T et al (1999) Analysis of paraaortic lymph node involvement in pancreatic carcinoma: a significant indication for surgery? Cancer 85:583–590CrossRefPubMed Kayahara M, Nagakawa T, Ohta T et al (1999) Analysis of paraaortic lymph node involvement in pancreatic carcinoma: a significant indication for surgery? Cancer 85:583–590CrossRefPubMed
6.
Zurück zum Zitat Schwarz M, Pauls S, Sokiranski R et al (2001) Is a preoperative multidiagnostic approach to predict surgical resectability of periampullary tumors still effective? Am J Surg 182:243–249CrossRefPubMed Schwarz M, Pauls S, Sokiranski R et al (2001) Is a preoperative multidiagnostic approach to predict surgical resectability of periampullary tumors still effective? Am J Surg 182:243–249CrossRefPubMed
7.
Zurück zum Zitat Soriano A, Castells A, Ayuso C et al (2004) Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol 99:492–501CrossRefPubMed Soriano A, Castells A, Ayuso C et al (2004) Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol 99:492–501CrossRefPubMed
8.
Zurück zum Zitat Parsons CM, Sutcliffe JL, Bold RJ (2008) Preoperative evaluation of pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg 15:429–435CrossRefPubMed Parsons CM, Sutcliffe JL, Bold RJ (2008) Preoperative evaluation of pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg 15:429–435CrossRefPubMed
9.
Zurück zum Zitat Japan Pancreas Society (2003) Classification of pancreatic carcinoma, 2nd English edn. Kanehara & Co., Tokyo Japan Pancreas Society (2003) Classification of pancreatic carcinoma, 2nd English edn. Kanehara & Co., Tokyo
10.
Zurück zum Zitat Sobin LH, Wittekind C (2002) TNM classification of malignant tumours, 6th edn. Wiley, New York Sobin LH, Wittekind C (2002) TNM classification of malignant tumours, 6th edn. Wiley, New York
11.
Zurück zum Zitat Committee on Classification of Regional Lymph Nodes of Japan Society of Clinical Oncology (2003) Classification of regional lymph nodes in Japan. Int J Clin Oncol 8:248–275CrossRef Committee on Classification of Regional Lymph Nodes of Japan Society of Clinical Oncology (2003) Classification of regional lymph nodes in Japan. Int J Clin Oncol 8:248–275CrossRef
12.
Zurück zum Zitat Yoshida T, Matsumoto T, Sasaki A et al (2004) Outcome of paraaortic node-positive pancreatic head and bile duct adenocarcinoma. Am J Surg 187:736–740CrossRefPubMed Yoshida T, Matsumoto T, Sasaki A et al (2004) Outcome of paraaortic node-positive pancreatic head and bile duct adenocarcinoma. Am J Surg 187:736–740CrossRefPubMed
13.
Zurück zum Zitat Shimada K, Sakamoto Y, Sano T et al (2006) The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma. J Am Coll Surg 203:345–352CrossRefPubMed Shimada K, Sakamoto Y, Sano T et al (2006) The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma. J Am Coll Surg 203:345–352CrossRefPubMed
14.
Zurück zum Zitat de Bondt RB, Nelemans PJ, Hofman PA et al (2007) Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. Eur J Radiol 64:266–272CrossRefPubMed de Bondt RB, Nelemans PJ, Hofman PA et al (2007) Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. Eur J Radiol 64:266–272CrossRefPubMed
15.
Zurück zum Zitat Hovels AM, Heesakkers RA, Adang EM et al (2008) The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol 63:387–395CrossRefPubMed Hovels AM, Heesakkers RA, Adang EM et al (2008) The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis. Clin Radiol 63:387–395CrossRefPubMed
16.
Zurück zum Zitat Karmazanovsky G, Fedorov V, Kubyshkin V et al (2005) Pancreatic head cancer: accuracy of CT in determination of resectability. Abdom Imaging 30:488–500CrossRefPubMed Karmazanovsky G, Fedorov V, Kubyshkin V et al (2005) Pancreatic head cancer: accuracy of CT in determination of resectability. Abdom Imaging 30:488–500CrossRefPubMed
17.
Zurück zum Zitat Roche CJ, Hughes ML, Garvey CJ et al (2003) CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. Am J Roentgenol 180:475–480 Roche CJ, Hughes ML, Garvey CJ et al (2003) CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. Am J Roentgenol 180:475–480
18.
Zurück zum Zitat Seo S, Doi R, Machimoto T et al (2008) Contribution of 18F-fluorodeoxyglucose positron-emission tomography to the diagnosis of early pancreatic carcinoma. J Hepatobiliary Pancreat Surg 15:634–639CrossRefPubMed Seo S, Doi R, Machimoto T et al (2008) Contribution of 18F-fluorodeoxyglucose positron-emission tomography to the diagnosis of early pancreatic carcinoma. J Hepatobiliary Pancreat Surg 15:634–639CrossRefPubMed
19.
Zurück zum Zitat Rose DM, Delbeke D, Beauchamp RD et al (1999) 18Fluorodeoxyglucose-positron-emission tomography in the management of patients with suspected pancreatic cancer. Ann Surg 229:729–737 (discussion 37–38)CrossRefPubMed Rose DM, Delbeke D, Beauchamp RD et al (1999) 18Fluorodeoxyglucose-positron-emission tomography in the management of patients with suspected pancreatic cancer. Ann Surg 229:729–737 (discussion 37–38)CrossRefPubMed
20.
Zurück zum Zitat Berberat P, Friess H, Kashiwagi M et al (1999) Diagnosis and staging of pancreatic cancer by positron-emission tomography. World J Surg 23:882–887CrossRefPubMed Berberat P, Friess H, Kashiwagi M et al (1999) Diagnosis and staging of pancreatic cancer by positron-emission tomography. World J Surg 23:882–887CrossRefPubMed
21.
Zurück zum Zitat Sperti C, Pasquali C, Chierichetti F et al (2001) Value of 18-fluorodeoxyglucose positron-emission tomography in the management of patients with cystic tumors of the pancreas. Ann Surg 234:675–680CrossRefPubMed Sperti C, Pasquali C, Chierichetti F et al (2001) Value of 18-fluorodeoxyglucose positron-emission tomography in the management of patients with cystic tumors of the pancreas. Ann Surg 234:675–680CrossRefPubMed
22.
Zurück zum Zitat Imdahl A, Nitzsche E, Krautmann F et al (1999) Evaluation of positron-emission tomography with 2-[18F]fluoro-2-deoxy-d-glucose for the differentiation of chronic pancreatitis and pancreatic cancer. Br J Surg 86:194–199CrossRefPubMed Imdahl A, Nitzsche E, Krautmann F et al (1999) Evaluation of positron-emission tomography with 2-[18F]fluoro-2-deoxy-d-glucose for the differentiation of chronic pancreatitis and pancreatic cancer. Br J Surg 86:194–199CrossRefPubMed
23.
Zurück zum Zitat Golder WA (2004) Lymph node diagnosis in oncologic imaging: a dilemma still waiting to be solved. Onkologie 27:194–199CrossRefPubMed Golder WA (2004) Lymph node diagnosis in oncologic imaging: a dilemma still waiting to be solved. Onkologie 27:194–199CrossRefPubMed
24.
Zurück zum Zitat Wunderbaldinger P (2006) Problems and prospects of modern lymph node imaging. Eur J Radiol 58:325–337CrossRefPubMed Wunderbaldinger P (2006) Problems and prospects of modern lymph node imaging. Eur J Radiol 58:325–337CrossRefPubMed
25.
Zurück zum Zitat Bares R, Dohmen BM, Cremerius U et al (1996) Results of positron-emission tomography with fluorine-18 labeled fluorodeoxyglucose in differential diagnosis and staging of pancreatic carcinoma. Radiologe 36:435–440CrossRefPubMed Bares R, Dohmen BM, Cremerius U et al (1996) Results of positron-emission tomography with fluorine-18 labeled fluorodeoxyglucose in differential diagnosis and staging of pancreatic carcinoma. Radiologe 36:435–440CrossRefPubMed
26.
Zurück zum Zitat Bares R, Klever P, Hauptmann S et al (1994) F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 192:79–86PubMed Bares R, Klever P, Hauptmann S et al (1994) F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 192:79–86PubMed
27.
Zurück zum Zitat Diederichs CG, Staib L, Vogel J et al (2000) Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas 20:109–116CrossRefPubMed Diederichs CG, Staib L, Vogel J et al (2000) Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas 20:109–116CrossRefPubMed
28.
Zurück zum Zitat Pakzad F, Groves AM, Ell PJ (2006) The role of positron-emission tomography in the management of pancreatic cancer. Semin Nucl Med 36:248–256CrossRefPubMed Pakzad F, Groves AM, Ell PJ (2006) The role of positron-emission tomography in the management of pancreatic cancer. Semin Nucl Med 36:248–256CrossRefPubMed
29.
Zurück zum Zitat Kim JK, Kim KA, Park BW et al (2008) Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: early experience. J Magn Reson Imaging 28:714–719CrossRefPubMed Kim JK, Kim KA, Park BW et al (2008) Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: early experience. J Magn Reson Imaging 28:714–719CrossRefPubMed
30.
Zurück zum Zitat Holzapfel K, Duetsch S, Fauser C et al (2008) Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Eur J Radiol 2008 (online first) Holzapfel K, Duetsch S, Fauser C et al (2008) Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Eur J Radiol 2008 (online first)
31.
Zurück zum Zitat Saokar A, Braschi M, Harisinghani M (2006) Lymphotrophic nanoparticle enhanced MR imaging (LNMRI) for lymph node imaging. Abdom Imaging 31:660–667CrossRefPubMed Saokar A, Braschi M, Harisinghani M (2006) Lymphotrophic nanoparticle enhanced MR imaging (LNMRI) for lymph node imaging. Abdom Imaging 31:660–667CrossRefPubMed
32.
Zurück zum Zitat Heesakkers RA, Hovels AM, Jager GJ et al (2008) MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol 9:850–856CrossRefPubMed Heesakkers RA, Hovels AM, Jager GJ et al (2008) MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol 9:850–856CrossRefPubMed
33.
Zurück zum Zitat Veit P, Ruehm S, Kuehl H et al (2006) Lymph node staging with dual-modality PET/CT: enhancing the diagnostic accuracy in oncology. Eur J Radiol 58:383–389CrossRefPubMed Veit P, Ruehm S, Kuehl H et al (2006) Lymph node staging with dual-modality PET/CT: enhancing the diagnostic accuracy in oncology. Eur J Radiol 58:383–389CrossRefPubMed
Metadaten
Titel
Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer
verfasst von
Hisashi Imai
Ryuichiro Doi
Hiroyuki Kanazawa
Naoko Kamo
Masayuki Koizumi
Toshihiko Masui
Yasuhiro Iwanaga
Yoshiya Kawaguchi
Yasutsugu Takada
Hiroyoshi Isoda
Shinji Uemoto
Publikationsdatum
01.06.2010
Verlag
Springer Japan
Erschienen in
International Journal of Clinical Oncology / Ausgabe 3/2010
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-010-0066-5

Weitere Artikel der Ausgabe 3/2010

International Journal of Clinical Oncology 3/2010 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.